We have located links that may give you full text access.
Evidence for the 'safety in density' effect for cyclists: validation of agent-based modelling results.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention 2018 October 13
The safety in numbers (SiN) effect for cyclists is widely observed but remains poorly understood. Although most studies investigating the SiN phenomenon have focused on behavioural adaptation to 'numbers' of cyclists in the road network, previous work in simulated environments has suggested SiN may instead be driven by increases in local cyclist spatial density, which prevents drivers from attempting to move through groups of oncoming cyclists. This study therefore set out to validate the results of prior simulation studies in a real-world environment. Time-gap analysis of cyclists passing through an intersection was conducted using 5 hours of video observation of a single intersection in the city of Melbourne, Australia, where motorists were required to 'yield' to oncoming cyclists. Results demonstrated that potential collisions between motor vehicles and cyclists reduced with increasing cyclists per minute passing through the intersection. These results successfully validate those observed under simulated conditions, supporting evidence of a proposed causal mechanism related to safety in density rather than SiN, per se. Implications of these results for transportation planners, cyclists and transportation safety researchers are discussed, suggesting that increased cyclist safety could be achieved through directing cyclists towards focused, strategic corridors rather than dispersed across a network.
Full text links
Related Resources
Trending Papers
A Systematic Review of Subclinical Hyperthyroidism Guidelines: a Remarkable Range of Recommendations.European Thyroid Journal 2024 May 2
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
2024 update in heart failure.ESC Heart Failure 2024 May 29
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.Cochrane Database of Systematic Reviews 2024 May 22
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app